1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Argentina Pharmaceuticals and Healthcare Report Q3 2016

Argentina Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 104 pages

Includes 3 FREE quarterly updates

BMI View: In the near term, the substandard regulatory and market access environment will continue totarnish Argentina's appeal to drugmakers. However, in the long term, Argentina stands among the mostpromising pharmaceutical markets in Latin America in terms of growth. In fact, rising demand andimprovements in the business environment are expected to translate in significant commercial andinvestment opportunities for drugmakers in the country over a multi-year horizon.

Headline Expenditure ProjectionsPharmaceuticals: ARS64.02bn (USD6.91bn) in 2015 to ARS79.31bn (USD5.18bn) in 2016; +23.9% inlocal currency terms and -25.0% in US dollar terms. Forecast revised slightly upwards in local currencyterms and slightly downwards in US dollar terms from last quarter.Healthcare: ARS243.93bn (USD26.33bn) in 2015 to ARS302.47bn (USD19.76bn) in 2016; +24.0% inlocal currency terms and -25.0% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Argentina Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceutical and Healthcare Forecasts (2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Argentina 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 27
OTC Medicines Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (Argentina 2014-2020) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (Argentina 2014-2020) 34
Industry Risk Reward Index 35
Americas Risk/Reward Index 35
Argentina Risk/Reward Index 40
Rewards 40
Risks 41
Regulatory Review 42
Table: Product Registration, Annex I and II Listed Countries 43
Intellectual Property Issues 50
Pricing Regime 55
Table: Pharmaceutical Price Build-Up 56
Reimbursement Regime 57
Market Overview 58
Healthcare Sector 59
Table: Healthcare Resources (Argentina 2010-2015) 62
Table: Healthcare Personnel (Argentina 2010-2015) 62
Table: Healthcare Activity (Argentina 2010-2015) 63
Research and Development 63
Clinical Trials 66
Epidemiology 68
Competitive Landscape 70
Research-Based Industry 71
Table: Multinational Market Activity 75
Generic Drugmakers 76
Pharmaceutical Distribution 78
Pharmaceutical Retail Sector 78
Company Profile 81
GlaxoSmithKline 81
Laboratorios Bago 84
Novartis 87
Sanofi 90
Demographic Forecast 93
Demographic Outlook 93
Table: Population Headline Indicators (Argentina 1990-2025) 94
Table: Key Population Ratios (Argentina 1990-2025) 94
Table: Urban/Rural Population and Life Expectancy (Argentina 1990-2025) 95
Table: Population By Age Group (Argentina 1990-2025) 95
Table: Population By Age Group % (Argentina 1990-2025) 96
Glossary 98
Methodology 100
Pharmaceutical Expenditure Forecast Model 100
Healthcare Expenditure Forecast Model 100
Notes On Methodology 101
Risk/Reward Index Methodology 102
Index Overview 103
Table: Pharmaceutical Risk/Reward Index Indicators 103
Indicator Weightings 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
OpportunityAnalyzer: Huntington’s Disease - Opportunity Analysis and Forecast to 2024

OpportunityAnalyzer: Huntington’s Disease - Opportunity Analysis and Forecast to 2024

  • $ 9 495
  • Industry report
  • May 2016
  • by Global Data

OpportunityAnalyzer: Huntington’s Disease - Opportunity Analysis and Forecast to 2024 Summary Huntington’s Disease (HD) is a rare, autosomal-dominant, neurodegenerative disorder, characterized by impaired ...

Asthma Pricing, Reimbursement, and Access

Asthma Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • May 2016
  • by Datamonitor Healthcare

Growth in the asthma market will be fueled by the introduction of new and expensive biologics, but companies will have to navigate access restrictions imposed by payers concerned about budget impact. This ...

Multiple Myeloma Pricing, Reimbursement, and Access

Multiple Myeloma Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • May 2016
  • by Datamonitor Healthcare

Growth in the multiple myeloma market will be spurred by the approval of novel drugs and the increasing role of combination therapy, but risk-sharing agreements will be key to entry into increasingly restrictive ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.